Skip to content

LIWOMA: what changed

BE 0804.674.287NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€85,154
2024 · €97,238-€12,084
Equity
€216,381
2024 · €131,227+€85,154
Cash
€264,152
2024 · €151,437+€112,715
Balance sheet total
€289,010
2024 · €173,132+€115,879

Largest movements

2024 to 2025
Assets
  • Cash +€112,715

    up €112,715 (+74.4%), from €151,437 to €264,152

    mainly Net result for the year (+€85,154) and Tax, wage and social debts (+€30,550)

  • Receivables within one year +€5,683

    up €5,683 (+35.7%), from €15,930 to €21,613

Equity and liabilities
  • Reserves +€85,154

    up €85,154 (+66.2%), from €128,727 to €213,881

  • Tax, wage and social debts +€30,550

    up €30,550 (+76.7%), from €39,807 to €70,357

Income statement
  • Gross operating margin -€15,368

    down €15,368 (-12.2%), from €125,858 to €110,490

  • Taxes -€3,515

    down €3,515 (-13.0%), from €26,972 to €23,457

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €97,238
Gross operating margin -€15,368
Depreciation -€354
Other operating charges -€2
Financial income +€0
Financial charges +€125
Taxes +€3,515
Result 2025 €85,154
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€112,715
Investment €0
Financing €0
Cash 2024 €151,437
Net result for the year +€85,154
Depreciation +€1,618
Receivables within one year -€5,683
Deferred charges and accrued income +€901
Trade debts +€174
Tax, wage and social debts +€30,550
Cash 2025 €264,152
brings cash intakes cash out
Every line side by side 35 lines
Line Code 2024 2025 Change %
Total assets 20/58 €173,132 €289,010 +€115,879 +66.9%
Fixed assets 21/28 €4,346 €2,728 -€1,618 -37.2%
Tangible fixed assets 22/27 €4,346 €2,728 -€1,618 -37.2%
Furniture and vehicles 24 €3,063 €1,590 -€1,473 -48.1%
Other tangible fixed assets 26 €1,283 €1,138 -€145 -11.3%
Current assets 29/58 €168,786 €286,282 +€117,497 +69.6%
Amounts receivable within one year 40/41 €15,930 €21,613 +€5,683 +35.7%
Trade receivables 40 €15,930 €21,613 +€5,683 +35.7%
Cash at bank and in hand 54/58 €151,437 €264,152 +€112,715 +74.4%
Deferred charges and accrued income 490/1 €1,418 €517 -€901 -63.5%
Total equity and liabilities 10/49 €173,132 €289,010 +€115,879 +66.9%
Equity 10/15 €131,227 €216,381 +€85,154 +64.9%
Contributions 10/11 €2,500 €2,500 = 0.0%
Reserves 13 €128,727 €213,881 +€85,154 +66.2%
Distributable reserves 133 €128,727 €213,881 +€85,154 +66.2%
Amounts payable 17/49 €41,905 €72,630 +€30,725 +73.3%
Amounts payable within one year 42/48 €41,772 €72,497 +€30,725 +73.6%
Trade debts 44 €371 €545 +€174 +47.0%
Suppliers 440/4 €371 €545 +€174 +47.0%
Taxes, remuneration and social security 45 €39,807 €70,357 +€30,550 +76.7%
Taxes 450/3 €39,807 €70,357 +€30,550 +76.7%
Other amounts payable 47/48 €1,595 €1,595 = 0.0%
Accrued charges and deferred income 492/3 €133 €133 = 0.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €1,264 €1,618 +€354 +28.0%
Other operating charges 640/8 €193 €195 +€2 +1.0%
Gross operating margin 9900 €125,858 €110,490 -€15,368 -12.2%
Operating profit (loss) 9901 €124,401 €108,677 -€15,724 -12.6%
Financial income 75/76B - €0 +€0
Recurring financial income 75 - €0 +€0
Financial charges 65/66B €191 €66 -€125 -65.4%
Recurring financial charges 65 €191 €66 -€125 -65.4%
Profit (loss) for the period before taxes 9903 €124,210 €108,611 -€15,599 -12.6%
Income taxes 67/77 €26,972 €23,457 -€3,515 -13.0%
Profit (loss) for the period 9904 €97,238 €85,154 -€12,084 -12.4%
Profit (loss) for the period to be appropriated 9905 €97,238 €85,154 -€12,084 -12.4%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€362,812 to €464,660

Midpoint €405,249 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €216,381
Capitalised earnings €509,243 to €712,940
Indication €362,812 to €464,660

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€216,381
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€216,381

Capitalised earnings

net result for the year (9904)
2025
€85,154
2024
€97,238
2023
€31,489
Average result
€71,294
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€509,243 / €594,117 / €712,940

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 18 November 2026 via checked.be.